II
ALXO icon

Inspire Investing’s ALX Oncology ALXO Stock Holding History

Inspire Investing’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-58,707
Closed -$354K – 832
2024
Q2 		$354K Buy
58,707
+25,551
+77% +$314K 0.04% 442
2024
Q1 		$370K Buy
+33,156
New +$466K 0.04% 414

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's ALXO Position: Q3 2024 in Review

Inspire Investing sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 58,707 shares — an estimated $354K sold.

Inspire Investing first reported a position in ALXO in Q1 2024 and held it in 2 quarters. The position peaked at $370K in Q1 2024. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Inspire Investing reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Inspire Investing sold 58,707 ALX Oncology shares in Q3 2024, an estimated $354K.
  • Inspire Investing first reported a position in ALX Oncology in Q1 2024 and held it in 2 quarters.
  • Inspire Investing's ALX Oncology position peaked at $370K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Inspire Investing's 13F filing for Q3 2024, filed 10 Oct 2024.